Podcast Episodes
Back to SearchCarlos Monteiro, Camila Corvalán, and Phil Baker on Ultra-Processed Foods and Human Health
Ultra-processed foods are on the rise. Despite the emphasis placed on individual responsibility, our deteriorating diets are primarily the result of the sophisticated political tactics of a powerful …
Published on 5 hours ago
Presented at ASH: the EPCORE FL-1 study on epcoritamab in follicular lymphoma
Franck Morschhauser joins Ben Abbott of The Lancet to discuss the phase 3 EPCORE FL-1 study on epcoritamab, lenalidomide, and rituximab for relapsed or refractory follicular lymphoma, which is being …
Published on 2 days, 16 hours ago
Presented at ESMO: the HARMONi-6 study on a bispecific antibody therapy for squamous NSCLC
Shun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer, which is being …
Published on 1 month, 2 weeks ago
Presented at ESMO: the POTOMAC study on immunotherapy in non-muscle-invasive bladder cancer
Neal Shore joins Ben Abbott of The Lancet to discuss the phase 3 POTOMAC trial of durvalumab plus BCG in BCG-naïve, high-risk non-muscle-invasive bladder cancer, which is being presented at ESMO 2025…
Published on 1 month, 3 weeks ago
Stephen Chan on the Lancet Commission on addressing the global hepatocellular carcinoma burden
With the global burden of liver cancer growing, The Lancet has commissioned an international panel of experts to identify strategies to strengthen the prevention, surveillance, diagnosis, and treatme…
Published on 4 months, 1 week ago
Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus
Early detection of oesophageal adenocarcinoma improves outcomes. Patients with the precursor lesion, Barrett's oesophagus, are recommended to undergo regular endoscopic surveillance, a process that c…
Published on 4 months, 2 weeks ago
ASCO 2025 Debrief
Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, and Katherine Gourd, Acting Deputy Editor at The Lancet Oncology, join Leon Terner to share some of their ex…
Published on 5 months, 4 weeks ago
Presented at ASCO: the first RCT of CAR T-cell therapy in solid tumours
Changsong Qi joins Chloe Wilson and Ben Abbott of The Lancet to discuss their recently published phase 2 randomised controlled trial investigating Claudin-18 isoform 2-specific CAR T-cell therapy for…
Published on 6 months, 1 week ago
Previewing ASCO 2025
Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, joins Gavin Cleaver to discuss what's being published at this year's American Society of Clinical Oncology (…
Published on 6 months, 1 week ago
Francis Couturaud on treatment of venous thromboembolism
Francis Couturaud joins Chloe Wilson of The Lancet to discuss the RENOVE trial, which looks at assessing the efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants in patient…
Published on 8 months, 3 weeks ago